Mobile

A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2g per day of strontium ranelate versus alendronate 70mg per week in women with postme...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-002732-22

A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2g per day of strontium ranelate versus alendronate 70mg per week in women with postmenopausal osteoporosis on bone microarchitecture measured by high resolution peripheral-Quantitative Computed Tomography (p-QCT)

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Assess the effects of strontium ranelate in comparison with alendronate on the bone microarchitecture in patients with postmenopausal osteoporosis

Critère d'inclusion

  • Treatment of postmenopausal Osteoporosis to reduce the risk of hip and vertebral fractures

Liens